Login | Register

Sector: University & Research Institutions

Stealthy biotech buys up patent portfolios in string of recent deals
Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

Columbia University scores $185 million jury verdict on back of anti virus patents
Columbia University scores $185 million jury verdict on back of anti virus patents

NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement

CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side
CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

Latest content

The Euro 100: positions 34 to 66

Featured in Special Report 2021 Q1: On the shoulders of giants

25 March 2021

Top European patent owners 2020 (part two)

Featured in Portfolio Data

25 March 2021

Top Chinese patent owners 2020 (part three)

Featured in Portfolio Data

25 March 2021

1,000 US patent club 2021 (part three)

Featured in Portfolio Data

25 March 2021

Top European patent owners 2020 (part three)

Featured in Portfolio Data

25 March 2021

The Euro 100: positions 1 to 33

Featured in Special Report 2021 Q1: On the shoulders of giants

25 March 2021

1,000 US patent club 2021 (part one)

Featured in Portfolio Data

25 March 2021

Top US patent filers: positions 1 to 100

Featured in Portfolio Data

25 March 2021

China’s top 100 patent filers: positions 1 to 33

Featured in Special Report 2021 Q1: On the shoulders of giants

25 March 2021

Staunch critic of Big Pharma IP strategies confirmed as US Health Secretary

Xavier Becerra may push for anti-patentee policies at HHS, but much remains unknown about the Biden administration’s approach

23 March 2021

Get unlimited access to all IAM content

Subscribe Now